Applying sputum as a diagnostic tool in pneumonia - limited yield, minimal impact on treatment decisions
S. Ewig, M. Schlochtermeier, N. Göke, M. S. Niederman (Bonn, Wesseling, Germany; Mineola, United States Of America)
Source: Annual Congress 2001 - Community-acquired pneumonia: from diagnosis to discharge
Disease area: Respiratory infections
Abstract OBJECTIVES. We evaluated the role of sputum in the management of patients with CAP in a primary care hospital without microbiological laboratory facilities. DESIGN AND INTERVENTIONS. Regular collection of sputum samples, Gram staining in a local laboratory, and mailing of samples for culture in a commercial laboratory were implemented as a diagnostic strategy. PATIENTS. 116 consecutive patients with CAP were prospectively recorded during a 12 month period. RESULTS. 42/116 (36%) patients were capable of producing a sputum sample. Age > 75 years (OR 0.4, 95% CI 0.18 - 0.93) and prior ambulutory antimicrobial treatment (OR 3.2, 95% CI 1.2 - 8.4) were independent predictors of sputum production. A delay in collection and processing of sputum samples was present in 31% and 39%, respectively. The former yielded an increased number of GNEB and nonfermenters (44% vs 7%, p = 0.056). The latter was associated with an increase of Candida spp. isolates (80% versus 6%, p = 0.003). The overall diagnostic yield was low (10 of 116, 8%) due to a limited number of valid samples (n = 23 of 42, 55%) and of definitely or probably positive samples in Gram stain and culture (n = 10 of 42, 24%). Prior ambulatory antimicrobial treatment was associated with a reduction in diagnostic yield (14% vs 56%, p = 0.09). The impact of diagnostic results on antimicrobial treatment decisions was minimal, with directed antimicrobial treatment according to diagnostic results in only one patient. CONCLUSIONS. We conclude that in this setting representative for primary care hospitals in Germany, sputum failed to be useful and should not form part of an initial management approach for the selection of initial antimicrobial treatment.
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Ewig, M. Schlochtermeier, N. Göke, M. S. Niederman (Bonn, Wesseling, Germany; Mineola, United States Of America). Applying sputum as a diagnostic tool in pneumonia - limited yield, minimal impact on treatment decisions. Eur Respir J 2001; 16: Suppl. 31, 3390
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
The standardised treatment of pulmonary TB: outcomes, problems and suggestions Source: Annual Congress 2005 - PG10 - The management of tuberculosis: tradition and novelties Year: 2005
What is the value of multiple sputum cultures in the routine investigation of community acquired pneumonia (CAP)? Source: Eur Respir J 2003; 22: Suppl. 45, 151s Year: 2003
We provided patients with patients oriented diagnosis and treatment advice from their lung assessments using an algorithm. It was feasible and in general well appreciated by our patients Source: International Congress 2016 – Screening, diagnosis, assessment, and treatment of COPD in primary care Year: 2016
The role of inhaled antibiotics in bronchial infection Source: Eur Respir Monogr 2013; 60: 120-126 Year: 2013
Clinical efficacy data for new diagnostic tool for the selection of the most effective antibiotics for patients with cystic fibrosis Source: Virtual Congress 2020 – Microbiology and antimicrobial strategies in cystic fibrosis Year: 2020
Sputum induction for assessment of biomarkers in early development of new drugs for respiratory disease in a proof of concept setting Source: International Congress 2016 – Airway biomarkers Year: 2016
The diagnostic yield of the pneumococcal urinary antigen test in clinical practice and its impact on antibiotic therapy Source: Annual Congress 2011 - Aetiology, diagnosis and outcomes in community-acquired pneumonia Year: 2011
Is PPD still a screening diagnostic tool for tuberculosis alone, or for something else also? Source: Eur Respir J 2006; 28: Suppl. 50, 21s Year: 2006
Quality-indicators and prognostics in CAP in three populations Source: Annual Congress 2005 - Community-acquired pneumonia: clinical approaches Year: 2005
External validation of a decision support system for respiratory primary care patients: A study of diagnostic accuracy Source: International Congress 2015 – Respiratory disease management in primary care Year: 2015
Community use of digital auscultation to improve diagnosis of childhood pneumonia in low resource setting Source: Virtual Congress 2020 – Aspects of acute and chronic airway infections in children Year: 2020
The impact of different reference standards when estimating the accuracy of tests for diagnosing asthma Source: International Congress 2018 – Primary care management of asthma Year: 2018
The clinical value of initial microbiological studies in exacerbations of COPD is questionable and not affected by antibiotics prior to hospitalization Source: Eur Respir J 2001; 18: Suppl. 33, 541s Year: 2001
Sputum: ready for clinical applications? Source: Annual Congress 2005 - PG6 - New and old methodologies to assess pathobiological markers in the lung and airways: from research into clinical practice Year: 2005
IGRA testing to diagnose TB disease and infection. What is new in clinical practice and for programmatic management Source: School Course 2012 - TB and M/XDR-TB: from clinical management to control and elimination Year: 2012
The influence of modern microbiological methods on the antibiotic treatment of pneumonia in children Source: International Congress 2018 – Paediatric respiratory infections: mechanistic insights and clinical outcomes Year: 2018
Treatment step-up strategy based on sputum eosinophil levels does not yield any better results than standard strategy Source: Eur Respir J 2005; 26: Suppl. 49, 574s Year: 2005
TB education - a method for better therapeutic results Source: Eur Respir J 2002; 20: Suppl. 38, 548s Year: 2002
First steps at implementing value based healthcare internationally in sarcoidosis: comparing outcomes. Source: International Congress 2017 – Respiratory epidemiology: from sarcoidosis to respiratory infections and tuberculosis Year: 2017
COPD detected with screening: impact on patient management and prognosis Source: Eur Respir J 2014; 44: 1571-1578 Year: 2014